These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 30409269)
1. Reshaping the Depressed Brain: A Focus on Synaptic Health. Gerhard DM; Ross DA Biol Psychiatry; 2018 Dec; 84(11):e73-e75. PubMed ID: 30409269 [No Abstract] [Full Text] [Related]
3. Electroencephalography technology for predicting response to antidepressant medications. Howland RH J Psychosoc Nurs Ment Health Serv; 2006 Oct; 44(10):11-4. PubMed ID: 17063885 [No Abstract] [Full Text] [Related]
4. A silver bullet for the treatment of depression? Duman RS Neuron; 2007 Sep; 55(5):679-81. PubMed ID: 17785173 [TBL] [Abstract][Full Text] [Related]
5. Functional brain circuits in major depression and remission. Sackeim HA Arch Gen Psychiatry; 2001 Jul; 58(7):649-50. PubMed ID: 11448370 [No Abstract] [Full Text] [Related]
7. Targeting opioid receptors: A new treatment for brain disorders. Rahman S CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):128. PubMed ID: 20401980 [No Abstract] [Full Text] [Related]
8. Perspective: Progress on the study and treatment of depressive illness. Carlezon WA; Chartoff E Neuropsychopharmacology; 2009 May; 34(6):1361-2. PubMed ID: 19242407 [No Abstract] [Full Text] [Related]
9. [Behavior of 5-HT receptors during long-term antidepressant treatment and at discontinuation]. Fillion G Encephale; 1995 Feb; 21 Spec No 1():3-6. PubMed ID: 7729352 [No Abstract] [Full Text] [Related]
10. Neuroscience basis of clinical depression: implications for future antidepressant drug development. Preskorn SH; Drevets WC J Psychiatr Pract; 2009 Mar; 15(2):125-32. PubMed ID: 19339846 [TBL] [Abstract][Full Text] [Related]
12. Targeting an old mechanism in a new disease-protection of glutamatergic dysfunction in depression. Sattler R; Rothstein JD Biol Psychiatry; 2007 Jan; 61(2):137-8. PubMed ID: 17223439 [No Abstract] [Full Text] [Related]